These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27449617)

  • 1. mRNA-Based Therapeutics - Advances and Perspectives.
    Sergeeva OV; Koteliansky VE; Zatsepin TS
    Biochemistry (Mosc); 2016 Jul; 81(7):709-22. PubMed ID: 27449617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Nanotechnology-Mediated Cancer Immunotherapy.
    Lin YX; Wang Y; Blake S; Yu M; Mei L; Wang H; Shi J
    Theranostics; 2020; 10(1):281-299. PubMed ID: 31903120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA delivery technologies: Toward clinical translation.
    Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
    Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo delivery of RNAi with lipid-based nanoparticles.
    Huang L; Liu Y
    Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy.
    Gao A; Hu XL; Saeed M; Chen BF; Li YP; Yu HJ
    Acta Pharmacol Sin; 2019 Sep; 40(9):1129-1137. PubMed ID: 31371782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.
    Phua KK
    J Immunol Res; 2015; 2015():680620. PubMed ID: 26819957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers.
    Yan Y; Xiong H; Zhang X; Cheng Q; Siegwart DJ
    Biomacromolecules; 2017 Dec; 18(12):4307-4315. PubMed ID: 29141136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA (mRNA) nanoparticle tumour vaccination.
    Phua KK; Nair SK; Leong KW
    Nanoscale; 2014 Jul; 6(14):7715-29. PubMed ID: 24904987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice.
    Rosigkeit S; Meng M; Grunwitz C; Gomes P; Kreft A; Hayduk N; Heck R; Pickert G; Ziegler K; Abassi Y; Röder J; Kaps L; Vascotto F; Beissert T; Witzel S; Kuhn A; Diken M; Schuppan D; Sahin U; Haas H; Bockamp E
    Mol Pharm; 2018 Sep; 15(9):3909-3919. PubMed ID: 30028629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine-Based Approaches for mRNA Delivery.
    Uchida S; Perche F; Pichon C; Cabral H
    Mol Pharm; 2020 Oct; 17(10):3654-3684. PubMed ID: 32845639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.
    Mukalel AJ; Riley RS; Zhang R; Mitchell MJ
    Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of nano drug-delivery system with cancer immunotherapy.
    Nakamura T; Harashima H
    Ther Deliv; 2017 Nov; 8(11):987-1000. PubMed ID: 29061103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes.
    Sayour EJ; Mendez-Gomez HR; Mitchell DA
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA.
    Pichon C; Midoux P
    Methods Mol Biol; 2013; 969():247-74. PubMed ID: 23296939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint.
    Granot Y; Peer D
    Semin Immunol; 2017 Dec; 34():68-77. PubMed ID: 28890238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.